Advanced Biomaterial Systems, Inc. (ABS) has changed the name of its proprietary Symphony™ VR Radiopaque Bone Cement to CONCERT® Spine VR Radiopaque Bone Cement for the fixation of pathological fractures of the vertebral body using vertebroplasty or kyphoplasty procedures. The name change unifies the proprietary bone cements of ABS under the CONCERT® brand name.

“ABS will continue to leverage the CONCERT® polymer formulation in the development of new medical grade polymers. The Company is committed to the advancement of new and innovative polymers that are biodegradable and therapeutic, as well as minimally invasive implantable systems” said Pete Carr, President and Chief Executive Officer of ABS.

ABS will be exhibiting its products at the American Society of Interventional and Therapeutic Neuroradiology (ASITN) course & workshop meeting in Oahu, Hawaii in August, the North American Spine Society (NASS) meeting in Philadelphia, PA in September, and the Advanced Interventional Management Symposium (AIM) in New York, NY in November.

About Advanced Biomaterial Systems, Inc.

Advanced Biomaterial Systems® (www.advbiomat.com) develops and markets proprietary biomaterials and delivery systems designed to advance procedure outcomes and patient safety. ABS’ products include: twistOR PrePack® - a patented mixing and delivery system prepackaged with ABS’ proprietary CONCERT® Bone Cement used for the fixation of prostheses to living bone in orthopaedic musculoskeletal surgical procedures; Plexis® Bone Void Filling System – a mixing and delivery system based on patented technology used for delivering biomaterials to site specific locations in minimally invasive procedures; CONCERT® Spine VR Radiopaque Bone Cement – a proprietary material used for the fixation of pathological fractures of the vertebral body in either vertebroplasty or kyphoplasty procedures; and CONCERT® Cranioplast - a proprietary radiopaque resinous material used for repairing cranial defects.

.: Back to Press Releases